Cinclus Pharma at Redeye Investor Forum in Gothenburg

Cinclus Pharma participates at Redeye Investor Forum in Gothenburg October 10th. Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of linaprazan glurate at 19:40. The event is also broadcasted live.